Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/87308
Título: | Taking the competitor's pill: when combination therapies enter pharmaceutical markets |
Autor(es): | Brekke, Kurt R. Dalen, Dag Morten Straume, Odd Rune |
Palavras-chave: | Pharmaceutical markets Combination therapies Therapeutic competition |
Data: | 2023 |
Editora: | Universidade do Minho. Núcleo de Investigação em Políticas Económicas (NIPE) |
Resumo(s): | We study the competitive effects of combination therapies in pharmaceutical markets, which crucially hinge on the additional therapeutic value of combinatory use of drugs and the therapeutic substitutability with the most relevant monotherapy. With large additional therapeutic value,the introduction of combination therapies leads to higher prices and, somewhat paradoxically, may reduce the health plan´s surplus. Although combination therapies imply that drugs become both substitutes and complements, we show that drug prices increase if the firms are allowed to coordinate their prices. Allowing for price discrimination might increase allocational effciency, but only at the expense of higher purchasing costs. |
Tipo: | Documento de trabalho |
URI: | https://hdl.handle.net/1822/87308 |
Versão da editora: | https://nipe.eeg.uminho.pt/publicacoes-nipe/#documentos-de-trabalho |
Arbitragem científica: | no |
Acesso: | Acesso aberto |
Aparece nas coleções: | NIPE - Documentos de Trabalho |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
WP-12.2023.pdf | Taking the competitor´s pill: When combination therapies enter pharmaceutical markets | 1,19 MB | Adobe PDF | Ver/Abrir |